PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Thompson Street Capital Partners portfolio company Isto Biologics acquires TheraCell

Into a portfolio company of private equity firm Thompson Street Capital Partners (TSCP), has acquired TheraCell, Inc, a California-based regenerative medicine company.

The acquisition will strengthen Isto’s focus on offering extraordinary solutions for surgical and clinical care procedures within spine, orthopedics, and sports medicine. Terms of the transaction were not disclosed.

The acquisition will expand Isto Biologics’ growing portfolio of orthopaedic grafts and introduce Theracell’s proprietary and patented TheraFuze DBF technology that will become part of Isto Biologics’ Influx line.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured